Review Article

[Retracted] Thyrotoxic Periodic Paralysis: Clinical Challenges

Table 1

Clinical features of TPP.

Clinical manifestations of thyrotoxic periodic paralysis

General
 Male predominance; initiation at age 20 to 40
 Periodic flaccid paralysis of proximal muscles, mainly of
 lower extremities
 Negative family history of similar symptoms
 Hypertension
 Subtle clinical features of hyperthyroidism
Laboratory findings
 Hypokalemia, hypophosphatemia, and mild hypomagnesemia
 Normal acid-base balance
 Low potassium excretion rate (low urinary potassium-
 creatinine ratio and low TTKG)
 Hypercalciuria and hypophosphaturia
 Abnormal thyroid function tests (low TSH; elevated free and
 total T4 and T3; increased T3 uptake)
Electrocardiographic abnormalities
 Sinus tachycardia
 Hypokalemic changes: prominent U wave, prolonged PR
 interval, increased
 P-wave amplitude, widened QRS complexes
 First-degree atrioventricular block
 Atrial and ventricular arrhythmias
Electromyography: low-amplitude compound muscle action
potential with no change after epinephrine.

TTKG indicates transtubular potassium gradient (a semiquantitative index of the activity of the potassium secretory process calculated as [urine K/(urine osmolality/plasma osmolality)]/plasma K); TSH: thyroid-stimulating hormone; T4: serum thyroxine; T3: triiodothyronine.